semaglutide and ovarian cancer GLP-1 Receptor Agonists Show Promise as Adjunctive Treatment for Good News on GLP-1s and

For instance, administration of FMT from ESKD patients to renal injured germ-free mice or antibiotic-treated rats resulted in an increased production of serum uraemic toxins, exacerbated renal fibrosis and oxidative stress, while control models with FMTs from healthy donors did not show these effects (Wang et al., 2020)

People with type 2 diabetes should monitor blood glucose closely during the starting period, as the addition of retatrutide may require adjustments to existing diabetes medications to prevent hypoglycemia

As the demand for medical weight loss solutions continues to rise, clinics are looking for seamless ways to integrate these services without adding operational burdens

The evidence base for GLP-1 receptor agonists in treating binge eating disorder remains preliminary but promising